Pipeline
Our Pipeline
Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational chemistry to discover small molecule drugs more efficiently than traditional approaches to deliver better medicines, faster.
R & D Pipeline
total pipeline depth
500+ Active Projects
protein AREAS
400+ Unique Targets
Targets with Validated Hits
80+ Targets with Validated Hits
Disease Areas
Atomwise has internal drug discovery programs across many disease areas including oncology, immunology, cardiology, neurology, and rare diseases.
Contact us to learn about licensing opportunities.
Co-Developed Pipeline
Co-Development
Partner
Disease Area
Target
Discovery
Optimization
Preclinical
Oncology
PIM3
Oncology
SHP2
Clotting Disorders
Factor XII
Immunology
cGAS
Neuroscience
GPCR
Neuroscience
Transcriptional Regulator
Oncology
undisclosed
Oncology
undisclosed